COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases
Revive Therapeutics announces key patent milestones for Bucillamine in medical countermeasures and infectious diseases, strengthening its strategic position -
-
-
-
COMMUNIQUÉ DE PRESSE
Kasowitz LLP Publishes an Updated Report Examining the Fundamental Due Process Defects Underlying the Continued Detention and Prosecution of Erion Veliaj, the Mayor of Tirana, Albania
Kasowitz LLP releases an updated report on due process defects in Mayor Veliaj's detention and prosecution in Tirana, Albania, highlighting SPAK's conduct and the need for intervention by the American government -
COMMUNIQUÉ DE PRESSE
WHO Foundation and Novo Nordisk Expand Collaboration to Provide Financial Support towards strengthening health systems for Cardio-Renal-Metabolic Diseases
WHO Foundation and Novo Nordisk expand collaboration to strengthen health systems for Cardio-Renal-Metabolic Diseases, with Novo Nordisk committing USD 7.9 million -
-
COMMUNIQUÉ DE PRESSE
Northfield Capital Announces Planned Name Change to Juno International Corp.
Northfield Capital Corporation announces it will change its name to Juno International Corp., reflecting the growth of Juno Corp. and expansion into international markets. Strategic move aligned with the company's ambitions -
COMMUNIQUÉ DE PRESSE
Gamma Resources Announces U.S. Listing on the OTCQB Venture Market Under the Symbol "GAMXF"
Gamma Resources Ltd. announces commencement of trading on OTCQB Venture Market under symbol 'GAMXF', enhancing visibility for U.S. investors. CEO Gabriel Alonso-Mendoza comments on the strategic move
